Form 4: Nuvation Bio Director Acquires Stock Options

Nuvation Bio Inc. reports that Director Vernon W. Anthony acquired stock options for 123,397 shares of Class A Common Stock.

Summary

• Director Vernon W. Anthony acquired 123,397 stock options for Nuvation Bio Inc. (NUVB).
• The options have an exercise price of $4.79 and an expiration date of May 20, 2036.
• Vesting is scheduled for the earlier of the one-year anniversary of the grant date (May 21, 2026) or the next shareholder annual meeting, contingent on continuous service.
• The transaction was reported on May 26, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a standard stock option grant to a director rather than a significant new development or financial performance indicator.

Positives

• Director acquisition of stock options can signal confidence in the company's future prospects.
• The acquisition of a significant number of options (123,397) suggests a long-term commitment from the director.

Future Outlook

The vesting schedule for the stock options is tied to the director's continuous service and specific company milestones, indicating a forward-looking incentive structure.

Industry Context

StockSavvy.ai notes that insider option grants are common in the biotechnology sector as a means to attract and retain key leadership talent, aligning their interests with long-term shareholder value.

Stakeholder Impact

• Shareholders: The grant of options to a director can be viewed positively as it aligns management's interests with long-term shareholder value, but it also represents potential future dilution if exercised.

Next Steps

• Continuous service by Director Vernon W. Anthony through the vesting dates.
• Potential exercise of stock options upon vesting, subject to market conditions and company performance.

Key Dates

Keywords

Nuvation Bio Inc., NUVB, Form 4, Stock Options, Director, Beneficial Ownership, Insider Trading